WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 2.45%3.08B | ---- | -6.57%1.24B | -1.26%3B | ---- | --1.32B | 9.59%3.04B | ---- | 18.27%2.77B | --2.35B |
Cash received relating to other operating activities | 3.29%40.18M | ---- | 11.06%13.97M | -21.17%38.9M | ---- | --12.58M | -7.28%49.35M | ---- | -1.58%53.22M | --54.08M |
Cash inflows from operating activities | 2.46%3.12B | ---- | -6.40%1.25B | -1.58%3.04B | ---- | --1.34B | 9.27%3.09B | ---- | 17.83%2.83B | --2.4B |
Goods services cash paid | -0.20%2.88B | ---- | -15.12%1.33B | 11.50%2.88B | ---- | --1.57B | -8.77%2.59B | ---- | 34.72%2.84B | --2.1B |
Staff behalf paid | -2.87%114.15M | ---- | 0.86%60.82M | 7.35%117.53M | ---- | --60.31M | 2.78%109.49M | ---- | 11.73%106.53M | --95.35M |
All taxes paid | -4.45%102.55M | ---- | 23.46%59.13M | 11.15%107.33M | ---- | --47.89M | 33.15%96.57M | ---- | -45.09%72.52M | --132.09M |
Cash paid relating to other operating activities | -26.33%63.88M | ---- | -23.14%31.29M | -11.34%86.71M | ---- | --40.72M | -20.90%97.8M | ---- | 22.14%123.64M | --101.23M |
Cash outflows from operating activities | -1.15%3.16B | ---- | -13.67%1.48B | 10.56%3.2B | ---- | --1.71B | -7.89%2.89B | ---- | 28.96%3.14B | --2.43B |
Net cash flows from operating activities | 72.03%-43.29M | 65.51%-133.53M | 39.42%-228.5M | -177.73%-154.75M | -241.42%-387.14M | ---377.18M | 164.11%199.09M | ---113.39M | -824.55%-310.55M | ---33.59M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50.5M |
Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --160.15K |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -80.88%26.88K | ---- | ---- | 34.65%140.6K | ---- | --57.23K | 143.09%104.42K | ---- | 139.98%42.96K | --17.9K |
Cash inflows from investing activities | -80.88%26.88K | ---- | ---- | 34.65%140.6K | ---- | --57.23K | 143.09%104.42K | ---- | -99.92%42.96K | --50.68M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -54.12%5.24M | ---- | -29.23%2.95M | -38.74%11.43M | ---- | --4.17M | 13.43%18.66M | ---- | -33.64%16.45M | --24.79M |
Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50.5M |
Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --430.45K |
Cash outflows from investing activities | -54.12%5.24M | ---- | -29.23%2.95M | -38.74%11.43M | ---- | --4.17M | 13.43%18.66M | ---- | -78.27%16.45M | --75.73M |
Net cash flows from investing activities | 53.79%-5.22M | ---- | 28.24%-2.95M | 39.16%-11.29M | ---- | ---4.11M | -13.09%-18.56M | ---- | 34.48%-16.41M | ---25.05M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30.93M |
Cash from borrowing | -50.88%250.15M | ---- | -55.17%158.82M | 2.80%509.29M | ---- | --354.26M | -29.88%495.41M | ---- | 51.56%706.49M | --466.15M |
Cash received relating to other financing activities | -63.74%9.01M | ---- | -50.72%8.93M | --24.85M | ---- | --18.12M | ---- | ---- | ---- | --15M |
Cash inflows from financing activities | -51.48%259.16M | ---- | -54.95%167.75M | 7.82%534.14M | ---- | --372.38M | -29.88%495.41M | ---- | 37.97%706.49M | --512.08M |
Borrowing repayment | 7.53%350.22M | ---- | 135.45%182M | -40.42%325.7M | ---- | --77.3M | 104.91%546.7M | ---- | 89.22%266.8M | --141M |
Dividend interest payment | -55.30%4.58M | ---- | -46.20%2.63M | -51.35%10.25M | ---- | --4.89M | 16.18%21.08M | ---- | -84.95%18.14M | --120.58M |
Cash payments relating to other financing activities | -83.27%2.01M | ---- | -96.41%79.5K | -50.67%12.03M | ---- | --2.22M | 60.53%24.38M | ---- | -92.67%15.19M | --207.3M |
Cash outflows from financing activities | 2.54%356.82M | ---- | 118.84%184.71M | -41.23%347.98M | ---- | --84.4M | 97.30%592.15M | ---- | -35.99%300.13M | --468.88M |
Net cash flows from financing activities | -152.46%-97.66M | ---- | -105.89%-16.96M | 292.42%186.16M | ---- | --287.98M | -123.81%-96.74M | ---- | 840.75%406.36M | --43.2M |
Net cash flow | ||||||||||
Net increase in cash and cash equivalents | -826.43%-146.16M | ---- | -166.20%-248.4M | -75.99%20.12M | ---- | ---93.31M | 5.52%83.79M | ---- | 614.25%79.4M | ---15.44M |
Add:Begin period cash and cash equivalents | 5.71%372.79M | ---- | 5.71%372.79M | 31.16%352.67M | ---- | --352.67M | 41.91%268.88M | ---- | -7.53%189.48M | --204.92M |
End period cash equivalent | -39.21%226.63M | ---- | -52.04%124.39M | 5.71%372.79M | ---- | --259.36M | 31.16%352.67M | ---- | 41.91%268.88M | --189.48M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | Unqualified opinion | -- | Unqualified opinion | Unqualified opinion |
Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.